JANET BENTON: Open Payments
NPI 1114039161 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 54 payments from 13 companies in 2025. Trend: 2023 $695 · 2024 $691 · 2025 $1,234
Food & beverage: $1,134Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $379 |
| ABBVIE INC. | 10 | $238 |
| Novartis Pharmaceuticals Corporation | 6 | $149 |
| GENZYME CORPORATION | 3 | $113 |
| PFIZER INC. | 5 | $79 |
| Incyte Corporation | 3 | $68 |
| Lilly USA, LLC | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| UCB, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, TALTZ, CIBINQO, COSENTYX, Rhapsido.
Industry payments across MD — which companies pay providers there.
